Why the study?
Does cardiopulmonary bypass induce an inflammatory response in patients undergoing aortocoronary bypass surgery?
Does cardiopulmonary bypass induce an inflammatory response in patients undergoing aortocoronary bypass surgery?
Cardiopulmonary bypass induces systemic inflammation, evidenced by complement activation and release of granulocyte factors, highlighting the need for improved biocompatibility of extracorporeal devices.
Answers are grounded in this paper and cite their sources.
Suggests CPB may trigger complement and granulocyte activation in bypass surgery; leaves open generalizability and device implications.
"Whole body inflammation" induced by cardiopulmonary bypass may play a role in the pathogenesis of postoperative complications after open-heart surgery. The inflammatory response, in terms of complement activation and release of granular proteins from neutrophil granulocytes, was investigated in six patients undergoing aortocoronary bypass surgery. Complement activation was demonstrated as well as substantially increased plasma levels of lactoferrin and myeloperoxidase--two granulocyte factors. The activation of inflammatory systems probably takes place on the artificial surfaces of the extracorporeal device. The biocompatibility of these components therefore should be further studied.
No takes yet. Share an insight, caveat, or question.
Nilsson et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: